Clinical trials offer the newest treatments available
Clinical trials are scientific studies that involve people to evaluate a new potential drug or therapy that’s already been studied in the laboratory. The trials are conducted to examine what dose is considered safe, how well it works and whether it’s more effective than current standard treatments. All standard-of-care drugs and treatments currently used were once studied in clinical trials.
Participating in a clinical trial is the only way to access the very latest drugs and treatments, often times years before a drug would become available to other providers.
Clinical trials at Roswell Park
Some of the options we have available for patients with ovarian, fallopian tube or primary peritoneal cancers include:
- Chimeric antigen receptor T-cell therapies. This cutting-edge immunotherapy uses your own T cells (immune cells), engineered to recognize cancer cells, as a “living” drug.
- New drugs and anti-cancer agents to target cancer cells.
- New combinations and sequencing of existing drugs
- New agents for RAS-mutated cancers
- New options for recurrent or advanced cancers.
- A personalized physical activity intervention to improve immune function, clinical outcomes and quality of life.
Available Clinical Trials
Why it matters
Ovarian cancer remains a challenging diagnosis. As many as 70 to 90% of patients experience recurrence and the need for new options to produce longer remissions remains urgent.
As a Comprehensive Cancer Center designated by the National Cancer Institute (NCI), Roswell Park’s researchers and clinicians are part of the worldwide effort to develop new and better cancer therapies. Roswell Park was selected to be part of an Ovarian Cancer Specialized Program of Research Excellence (SPORE), funded by the NCI, which focuses research on immune-based approaches in ovarian cancer.